Lundbeck joins forces with Danish Centre for AI Innovation to improve brain health by advancing drug discovery with Gefion AI supercomputer

Lundbeck joins forces with Danish Centre for AI Innovation to improve brain health by advancing drug discovery with Gefion AI supercomputer

VALBY, Denmark, May 6, 2025 /PRNewswire/ — H. Lundbeck A/S is pleased to announce its agreement with the Danish Centre for AI Innovation (DCAI), the company established to run and operate Gefion, Denmark’s flagship AI supercomputer. Lundbeck is one of the first pharmaceutical companies to leverage Gefion to accelerate drug discovery and development in neurological and psychiatric disorders. Brain disorders are estimated to affect half the world’…

The Gefion supercomputer, of which the Novo Nordisk Foundation is the main owner, has acquired the pharmaceutical company Lundbeck as a customer. This gives Lundbeck access to computing power that can boost the development of new drugs.